| Literature DB >> 25290397 |
G Krämer1, K Schauenstein, G Wick.
Abstract
Because it has a role in lymphocyte activation, interleukin 2 (IL-2) has been tried as a therapeutic agent in several types of immune dysfunction in animals and man. Here, Georg Wick and his colleagues discuss the possibility that IL-2 production initiates and perpetuates autoimmune disease, and express caution about the clinical use of IL-2.Entities:
Year: 1986 PMID： 25290397 DOI： 10.1016/0167-5699(86)90102-7
Source DB: PubMed Journal: Immunol Today ISSN： 0167-5699